Immune interactions in endometriosis

References

• Bulun SE. Endometriosis. N. Engl. J. Med.360(3), 268–279 (2009).
   PubMed Web of Science ®Google Scholar
• Benagiano G, Brosens I. The history of endometriosis: identifying the disease. Hum. Reprod.6(7), 963–968 (1991).
   PubMed Web of Science ®Google Scholar
• Diesterweg A. Ein Fall von Cystofibroma uteri verum. Z. Geburtshilfe9, 191–195 (1883).
   Google Scholar
• Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am. J. Pathol.3(2), 93–110 143 (1927).
   PubMedGoogle Scholar
• El-Mahgoub S, Yaseen S. A positive proof for the theory of coelomic metaplasia. Am. J. Obstet. Gynecol.137(1), 137–140 (1980).
   PubMed Web of Science ®Google Scholar
• Meyer R. Ueber eine adenomatose Wucherung der Serosa in einer Banchuabe. Zeit. Gerburt. Gynak.49, 32–38 (1903).
   Google Scholar
• Meyer R. Ueber den stand der Frage der Adenomyositis und Adenomyome in algemeinen und insbesondere iiber Adenomyositis serosoeithelialis und Adenomyometritis sarcomatosa. Zentralbl. Gyndkol.43, 745–750 (1919).
   Google Scholar
• Nakamura M, Katabuchi H, Tohya T, Fukumatsu Y, Matsuura K, Okamura H. Scanning electron microscopic and immunohistochemical studies of pelvic endometriosis. Hum. Reprod.8(12), 2218–2226 (1993).
   PubMedGoogle Scholar
• Batt RE, Smith RA. Embryologic theory of histogenesis of endometriosis in peritoneal pockets. Obstet. Gynecol. Clin. North Am.16(1), 15–28 (1989).
   PubMedGoogle Scholar
• Batt RE, Smith RA, Buck GM, Severino MF, Naples JD. Mullerianosis. Prog. Clin. Biol. Res.323, 413–426 (1990).
   PubMedGoogle Scholar
• Halban J. Hysteroadenosis metastatica. Zentralbl. Gynakol.7, 387–391 (1925).
   Google Scholar
• Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis. Ann. NY Acad. Sci.1127, 106–115 (2008).
   PubMed Web of Science ®Google Scholar
• Fujii S. Secondary mullerian system and endometriosis. Am. J. Obstet. Gynecol.165(1), 219–225 (1991).
   PubMedGoogle Scholar
• Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum. Reprod.17(10), 2715–2724 (2002).
   PubMed Web of Science ®Google Scholar
• Shepperson Mills D, Vernon M. Endometriosis: A Key to Healing Through Nutrition. Element Books Limited, Boston, MA, USA (1999).
   Google Scholar
• Revised American Fertility Society classification of endometriosis: 1985. Fertil. Steril.43(3), 351–352 (1985).
   PubMed Web of Science ®Google Scholar
• Gupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, Agarwal A. Pathogenic mechanisms in endometriosis-associated infertility. Fertil. Steril.90(2), 247–257 (2008).
   PubMed Web of Science ®Google Scholar
• Tomassetti C, Meuleman C, Pexsters A et al. Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? Reprod. Biomed. Online13(1), 58–64 (2006).
   PubMed Web of Science ®Google Scholar
• Weiss G, Goldsmith LT, Taylor RN, Bellet D, Taylor HS. Inflammation in reproductive disorders. Reprod. Sci.16(2), 216–229 (2009).
   PubMed Web of Science ®Google Scholar
• Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis associated with systemic subclinical inflammation? Gynecol. Obstet. Invest.62(3), 139–147 (2006).
   PubMed Web of Science ®Google Scholar
• Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem. Sci.30(1), 43–52 (2005).
   PubMed Web of Science ®Google Scholar
• Cao WG, Morin M, Sengers V et al. Tumour necrosis factor-α up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-κB. Hum. Reprod.21(2), 421–428 (2006).
   PubMedGoogle Scholar
• Sugino N, Karube-Harada A, Sakata A, Takiguchi S, Kato H. Nuclear factor-κ B is required for tumor necrosis factor-α-induced manganese superoxide dismutase expression in human endometrial stromal cells. J. Clin. Endocrinol. Metab.87(8), 3845–3850 (2002).
   PubMedGoogle Scholar
• Gonzalez-Ramos R, Donnez J, Defrere S et al. Nuclear factor-κ B is constitutively activated in peritoneal endometriosis. Mol. Hum. Reprod.13(7), 503–509 (2007).
   PubMed Web of Science ®Google Scholar
• Okino ST, Whitlock JP Jr. The aromatic hydrocarbon receptor, transcription, and endocrine aspects of dioxin action. Vitam. Horm.59, 241–264 (2000).
   PubMedGoogle Scholar
• Kerkvliet NI. AHR-mediated immunomodulation: the role of altered gene transcription. Biochem. Pharmacol.77(4), 746–760 (2009).
   PubMed Web of Science ®Google Scholar
• Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol.21(4), 433–441 (1993).
   PubMedGoogle Scholar
• Birnbaum LS. Endocrine effects of prenatal exposure to PCBs, dioxins, and other xenobiotics: implications for policy and future research. Environ. Health Perspect.102(8), 676–679 (1994).
   PubMed Web of Science ®Google Scholar
• Fierens S, Mairesse H, Heilier JF et al. Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers8(6), 529–534 (2003).
   PubMed Web of Science ®Google Scholar
• Heilier JF, Nackers F, Verougstraete V, Tonglet R, Lison D, Donnez J. Increased dioxin-like compounds in the serum of women with peritoneal endometriosis and deep endometriotic (adenomyotic) nodules. Fertil. Steril.84(2), 305–312 (2005).
   PubMed Web of Science ®Google Scholar
• Pauwels A, Schepens PJ, D’Hooghe T et al. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case-control study of infertile women. Hum. Reprod.16(10), 2050–2055 (2001).
   PubMed Web of Science ®Google Scholar
• Porpora MG, Ingelido AM, Di Domenico A et al. Increased levels of polychlorobiphenyls in Italian women with endometriosis. Chemosphere63(8), 1361–1367 (2006).
   PubMed Web of Science ®Google Scholar
• Koninckx PR. The physiopathology of endometriosis: pollution and dioxin. Gynecol. Obstet. Invest.47(Suppl. 1), 47–49; discussion 50 (1999).
   PubMed Web of Science ®Google Scholar
• Bruner-Tran KL, Ding T, Osteen KG. Dioxin and endometrial progesterone resistance. Semin. Reprod. Med.28(1), 59–68 (2010).
   PubMedGoogle Scholar
• Bruner-Tran KL, Osteen KG. Dioxin-like PCBs and endometriosis. Syst. Biol. Reprod. Med.56(2), 132–146 (2010).
   PubMed Web of Science ®Google Scholar
• Heindel JJ. Role of exposure to environmental chemicals in the developmental basis of reproductive disease and dysfunction. Semin. Reprod. Med.24(3), 168–177 (2006).
   PubMed Web of Science ®Google Scholar
• Nayyar T, Bruner-Tran KL, Piestrzeniewicz-Ulanska D, Osteen KG. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod. Toxicol.23(3), 326–336 (2007).
   PubMed Web of Science ®Google Scholar
• Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum. Reprod.16(9), 1802–1808 (2001).
   PubMed Web of Science ®Google Scholar
• Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G. Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’. Eur. J. Contracept. Reprod. Health Care12(3), 194–202 (2007).
   PubMed Web of Science ®Google Scholar
• Paul Dmowski W, Braun DP. Immunology of endometriosis. Best Pract. Res. Clin. Obstet. Gynaecol.18(2), 245–263 (2004).
   PubMedGoogle Scholar
• Kaminski K, Kotarski J, Gogacz M. Characterization of cellular components in the peritoneal fluid and in the endometrial tissue of women with endometriosis. Arch. Immunol. Ther. Exp. (Warsz)43(5–6), 247–252 (1995).
   PubMedGoogle Scholar
• Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil. Steril.58(2), 290–295 (1992).
   PubMed Web of Science ®Google Scholar
• Braun DP, Gebel H, House R, Rana N, Dmowski NP. Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis. Fertil. Steril.65(6), 1125–1129 (1996).
   PubMed Web of Science ®Google Scholar
• Rana N, Braun DP, House R, Gebel H, Rotman C, Dmowski WP. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil. Steril.65(5), 925–930 (1996).
   PubMed Web of Science ®Google Scholar
• Zeller JM, Henig I, Radwanska E, Dmowski WP. Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am. J. Reprod. Immunol. Microbiol.13(3), 78–82 (1987).
   PubMed Web of Science ®Google Scholar
• Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today.16(1), 21–26 (1995).
   PubMedGoogle Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature454(7203), 436–444 (2008).
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil. Steril.75(1), 1–10 (2001).
   PubMed Web of Science ®Google Scholar
• Osteen KG, Yeaman GR, Bruner-Tran KL. Matrix metalloproteinases and endometriosis. Semin. Reprod. Med.21(2), 155–164 (2003).
   PubMed Web of Science ®Google Scholar
• Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest.108(6), 785–791 (2001).
   PubMed Web of Science ®Google Scholar
• Linton MF, Fazio S. Class A scavenger receptors, macrophages, and atherosclerosis. Curr. Opin. Lipidol.12(5), 489–495 (2001).
   PubMed Web of Science ®Google Scholar
• Critchley HO, Kelly RW, Brenner RM, Baird DT. The endocrinology of menstruation – a role for the immune system. Clin. Endocrinol. (Oxf)55(6), 701–710 (2001).
   PubMed Web of Science ®Google Scholar
• Wu MH, Shoji Y, Wu MC et al. Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. Am. J. Pathol.167(4), 1061–1069 (2005).
   PubMed Web of Science ®Google Scholar
• De Villiers WJ, Fraser IP, Gordon S. Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. Immunol. Lett.43(1–2), 73–79 (1994).
   PubMed Web of Science ®Google Scholar
• Chuang PC, Wu MH, Shoji Y, Tsai SJ. Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis. J. Pathol.219(2), 232–241 (2009).
   PubMed Web of Science ®Google Scholar
• Dmowski WP, Braun D, Gebel H. Endometriosis: genetic and immunologic aspects. Prog. Clin. Biol. Res.323, 99–122 (1990).
   PubMedGoogle Scholar
• Halme J, Becker S, Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am. J. Obstet. Gynecol.148(1), 85–90 (1984).
   PubMed Web of Science ®Google Scholar
• Han J, Hajjar DP, Tauras JM, Feng J, Gotto AM Jr, Nicholson AC. Transforming growth factor-β1 (TGF-β1) and TGF-β2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-γ. J. Biol. Chem.275(2), 1241–1246 (2000).
   PubMed Web of Science ®Google Scholar
• Huang JT, Welch JS, Ricote M et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature400(6742), 378–382 (1999).
   PubMed Web of Science ®Google Scholar
• Herington JL, Crispens MA, Carvalho-Macedo AC et al. Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis. Fertil. Steril.95(4), 1295–1301 e1 (2011).
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Kir M, Casey CL. Peroxisome proliferator-activated receptor-γ induces regression of endometrial explants in a rat model of endometriosis. Fertil. Steril.82(Suppl. 3), 1008–1013 (2004).
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Mwenda JM, Chai DC, Santi A, Xu X, D’hooghe T. Peroxisome proliferator-activated receptor-(γ) receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study. Endocrinology151(4), 1846–1852 (2010).
   PubMed Web of Science ®Google Scholar
• Chuang PC, Lin YJ, Wu MH, Wing LY, Shoji Y, Tsai SJ. Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis. Am. J. Pathol.176(2), 850–860 (2010).
   PubMedGoogle Scholar
• Somigliana E, Vigano P, Gaffuri B, Guarneri D, Busacca M, Vignali M. Human endometrial stromal cells as a source of soluble intercellular adhesion molecule (ICAM)-1 molecules. Hum. Reprod.11(6), 1190–1194 (1996).
   PubMed Web of Science ®Google Scholar
• Vigano P, Gaffuri B, Somigliana E, Busacca M, Di Blasio AM, Vignali M. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol. Hum. Reprod.4(12), 1150–1156 (1998).
   PubMed Web of Science ®Google Scholar
• Dmowski WP, Gebel HM, Braun DP. The role of cell-mediated immunity in pathogenesis of endometriosis. Acta. Obstet. Gynecol. Scand. Suppl.159, 7–14 (1994).
   PubMedGoogle Scholar
• Hill JA, Faris HM, Schiff I, Anderson DJ. Characterization of leukocyte subpopulations in the peritoneal fluid of women with endometriosis. Fertil. Steril.50(2), 216–222 (1988).
   PubMedGoogle Scholar
• Raiter-Tenenbaum A, Baranao RI, Etchepareborda JJ, Meresman GF, Rumi LS. Functional and phenotypic alterations in peritoneal macrophages from patients with early and advanced endometriosis. Arch. Gynecol. Obstet.261(3), 147–157 (1998).
   PubMed Web of Science ®Google Scholar
• Hsu CC, Lin YS, Wang ST, Huang KE. Immunomodulation in women with endometriosis receiving GnRH agonist. Obstet. Gynecol.89(6), 993–998 (1997).
   PubMedGoogle Scholar
• Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil. Steril.56(1), 45–51 (1991).
   PubMed Web of Science ®Google Scholar
• Wilson TJ, Hertzog PJ, Angus D, Munnery L, Wood EC, Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil. Steril.62(5), 1086–1088 (1994).
   PubMedGoogle Scholar
• Wu MY, Yang JH, Chao KH, Hwang JL, Yang YS, Ho HN. Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertil. Steril.74(6), 1187–1191 (2000).
   PubMed Web of Science ®Google Scholar
• Ota H, Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil. Steril.60(5), 834–838 (1993).
   PubMedGoogle Scholar
• Semino C, Semino A, Pietra G et al. Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. Fertil. Steril.64(5), 909–916 (1995).
   PubMed Web of Science ®Google Scholar
• Harada T, Kaponis A, Iwabe T et al. Apoptosis in human endometrium and endometriosis. Hum. Reprod. Update10(1), 29–38 (2004).
   PubMed Web of Science ®Google Scholar
• Tariverdian N, Siedentopf F, Rucke M et al. Intraperitoneal immune cell status in infertile women with and without endometriosis. J. Reprod. Immunol.80(1–2), 80–90 (2009).
   PubMed Web of Science ®Google Scholar
• Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol.73, 369–509 (1999).
   PubMed Web of Science ®Google Scholar
• Riley CF, Moen MH, Videm V. Inflammatory markers in endometriosis: reduced peritoneal neutrophil response in minimal endometriosis. Acta. Obstet. Gynecol. Scand.86(7), 877–881 (2007).
   PubMedGoogle Scholar
• Mueller MD, Mazzucchelli L, Buri C, Lebovic DI, Dreher E, Taylor RN. Epithelial neutrophil-activating peptide 78 concentrations are elevated in the peritoneal fluid of women with endometriosis. Fertil. Steril.79(Suppl. 1), 815–820 (2003).
   PubMedGoogle Scholar
• Hirata T, Osuga Y, Hamasaki K et al. Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology149(3), 1260–1267 (2008).
   PubMed Web of Science ®Google Scholar
• Hirata T, Osuga Y, Takamura M et al. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 β-, TNF-α-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology151(11), 5468–5476 (2010).
   PubMed Web of Science ®Google Scholar
• Steele RW, Dmowski WP, Marmer DJ. Immunologic aspects of human endometriosis. Am. J. Reprod. Immunol.6(1), 33–36 (1984).
   PubMed Web of Science ®Google Scholar
• Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y. Lymphocytes in endometriosis. Am. J. Reprod. Immunol.65(1), 1–10 (2011).
   PubMed Web of Science ®Google Scholar
• Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol. Med.9(5), 223–228 (2003).
   PubMed Web of Science ®Google Scholar
• Ouyang Z, Hirota Y, Osuga Y et al. Interleukin-4 stimulates proliferation of endometriotic stromal cells. Am. J. Pathol.173(2), 463–469 (2008).
   PubMedGoogle Scholar
• Podgaec S, Abrao MS, Dias JA Jr, Rizzo LV, De Oliveira RM, Baracat EC. Endometriosis: an inflammatory disease with a Th2 immune response component. Hum. Reprod.22(5), 1373–1379 (2007).
   PubMed Web of Science ®Google Scholar
• Fakih H, Baggett B, Holtz G, Tsang KY, Lee JC, Williamson HO. Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil. Steril.47(2), 213–217 (1987).
   PubMed Web of Science ®Google Scholar
• Hill JA, Anderson DJ. Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with and without endometriosis. Am. J. Obstet. Gynecol.161(4), 861–864 (1989).
   PubMedGoogle Scholar
• Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR. IL-1 β, TNF-α, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am. J. Reprod. Immunol.34(6), 381–385 (1995).
   PubMed Web of Science ®Google Scholar
• Mori H, Sawairi M, Nakagawa M, Itoh N, Wada K, Tamaya T. Peritoneal fluid interleukin-1 β and tumor necrosis factor in patients with benign gynecologic disease. Am. J. Reprod. Immunol.26(2), 62–67 (1991).
   PubMed Web of Science ®Google Scholar
• Laird SM, Li TC, Bolton AE. The production of placental protein 14 and interleukin 6 by human endometrial cells in culture. Hum. Reprod.8(6), 793–798 (1993).
   PubMedGoogle Scholar
• Tabibzadeh SS, Santhanam U, Sehgal PB, May LT. Cytokine-induced production of IFN-β 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 β. J. Immunol.142(9), 3134–3139 (1989).
   PubMedGoogle Scholar
• Bedaiwy MA, Falcone T, Sharma RK et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum. Reprod.17(2), 426–431 (2002).
   PubMed Web of Science ®Google Scholar
• Darai E, Detchev R, Hugol D, Quang NT. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-α in women with endometriomas and benign and malignant cystic ovarian tumours. Hum. Reprod.18(8), 1681–1685 (2003).
   PubMed Web of Science ®Google Scholar
• Iwabe T, Harada T, Sakamoto Y et al. Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas. Fertil. Steril.80(2), 300–304 (2003).
   PubMed Web of Science ®Google Scholar
• Martinez S, Garrido N, Coperias Jl et al. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum. Reprod.22(3), 836–842 (2007).
   PubMed Web of Science ®Google Scholar
• Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simon C. The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil. Steril.70(3), 425–431 (1998).
   PubMed Web of Science ®Google Scholar
• Othman Eel-D Hd, Salem HT, Khalifa EA, El-Metwally TH, Al-Hendy A. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol.137(2), 240–246 (2008).
   PubMedGoogle Scholar
• Jee BC, Suh CS, Kim SH, Moon SY. Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas. Gynecol. Obstet. Invest.66(1), 47–52 (2008).
   PubMed Web of Science ®Google Scholar
• Kalu E, Sumar N, Giannopoulos T et al. Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis. J. Obstet. Gynaecol. Res.33(4), 490–495 (2007).
   PubMed Web of Science ®Google Scholar
• Seeber B, Sammel MD, Fan X et al. Panel of markers can accurately predict endometriosis in a subset of patients. Fertil. Steril.89(5), 1073–1081 (2008).
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett.307(1), 97–101 (1992).
   PubMed Web of Science ®Google Scholar
• Gazvani MR, Christmas S, Quenby S, Kirwan J, Johnson PM, Kingsland CR. Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease. Hum. Reprod.13(7), 1957–1961 (1998).
   PubMedGoogle Scholar
• Pizzo A, Salmeri FM, Ardita FV, Sofo V, Tripepi M, Marsico S. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol. Obstet. Invest.54(2), 82–87 (2002).
   PubMed Web of Science ®Google Scholar
• Kim JY, Lee DH, Joo JK et al. Effects of peritoneal fluid from endometriosis patients on interferon-γ-induced protein-10 (CXCL10) and interleukin-8 (CXCL8) released by neutrophils and CD4+ T cells. Am. J. Reprod. Immunol.62(3), 128–138 (2009).
   PubMedGoogle Scholar
• Oral E, Olive DL, Arici A. The peritoneal environment in endometriosis. Hum. Reprod. Update2(5), 385–398 (1996).
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Leonard EJ. Secretion by human fibroblasts of monocyte chemoattractant protein-1, the product of gene JE. J. Immunol.144(6), 2377–2383 (1990).
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett.244(2), 487–493 (1989).
   PubMed Web of Science ®Google Scholar
• Arici A, Oral E, Attar E, Tazuke SI, Olive DL. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil. Steril.67(6), 1065–1072 (1997).
   PubMed Web of Science ®Google Scholar
• Khorram O, Taylor RN, Ryan IP, Schall TJ, Landers DV. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am. J. Obstet. Gynecol.169(6), 1545–1549 (1993).
   PubMed Web of Science ®Google Scholar
• Wieser F, Dogan S, Klingel K, Diedrich K, Taylor RN, Hornung D. Expression and regulation of CCR1 in peritoneal macrophages from women with and without endometriosis. Fertil. Steril.83(6), 1878–1881 (2005).
   PubMed Web of Science ®Google Scholar
• Debrock S, De Strooper B, Vander Perre S, Hill JA, D’hooghe TM. Tumour necrosis factor-α, interleukin-6 and interleukin-8 do not promote adhesion of human endometrial epithelial cells to mesothelial cells in a quantitative in vitro model. Hum. Reprod.21(3), 605–609 (2006).
   PubMed Web of Science ®Google Scholar
• Cho SH, Oh YJ, Nam A et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am. J. Reprod. Immunol.58(6), 497–504 (2007).
   PubMed Web of Science ®Google Scholar
• Matalliotakis I, Neonaki M, Zolindaki A, Hassan E, Georgoulias V, Koumantakis E. Changes in immunologic variables (TNF-α, sCD8 and sCD4) during danazol treatment in patients with endometriosis. Int. J. Fertil. Womens Med.42(3), 211–214 (1997).
   PubMedGoogle Scholar
• Xavier P, Belo L, Beires J et al. Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis. Arch. Gynecol. Obstet.273(4), 227–231 (2006).
   PubMedGoogle Scholar
• Eisermann J, Gast MJ, Pineda J, Odem RR, Collins JL. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil. Steril.50(4), 573–579 (1988).
   PubMed Web of Science ®Google Scholar
• Mclaren J, Prentice A, Charnock-Jones DS et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest.98(2), 482–489 (1996).
   PubMed Web of Science ®Google Scholar
• Mueller MD, Lebovic DI, Garrett E, Taylor RN. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil. Steril.74(1), 107–112 (2000).
   PubMedGoogle Scholar
• Shifren JL, Tseng JF, Zaloudek CJ et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab.81(8), 3112–3118 (1996).
   PubMed Web of Science ®Google Scholar
• Becker CM, D’Amato RJ. Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc. Res.74(2–3), 121–130 (2007).
   PubMed Web of Science ®Google Scholar
• Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann. NY Acad. Sci.955, 89–100; discussion 118, 396–406 (2002).
   PubMed Web of Science ®Google Scholar
• Hull ML, Charnock-Jones DS, Chan Cl et al. Antiangiogenic agents are effective inhibitors of endometriosis. J. Clin. Endocrinol. Metab.88(6), 2889–2899 (2003).
   PubMed Web of Science ®Google Scholar
• Novella-Maestre E, Carda C, Noguera I et al. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum. Reprod.24(5), 1025–1035 (2009).
   PubMed Web of Science ®Google Scholar
• D’hooghe TM, Debrock S, Meuleman C, Hill JA, Mwenda JM. Future directions in endometriosis research. Obstet. Gynecol. Clin. North Am.30(1), 221–244 (2003).
   PubMed Web of Science ®Google Scholar
• Osteen KG, Bruner-Tran KL, Eisenberg E. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil. Steril.83(3), 529–537 (2005).
   PubMed Web of Science ®Google Scholar
• Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J. Clin. Invest.114(9), 1209–1217 (2004).
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Bates GJ, Koukourakis MI et al. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. Gynecol. Oncol.110(2), 216–221 (2008).
   PubMed Web of Science ®Google Scholar
• Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol.178(4), 2572–2578 (2007).
   PubMed Web of Science ®Google Scholar
• Berbic M, Hey-Cunningham AJ, Ng C et al. The role of FOXP3+ regulatory T-cells in endometriosis: a potential controlling mechanism for a complex, chronic immunological condition. Hum. Reprod.25(4), 900–907 (2010).
   PubMed Web of Science ®Google Scholar
• Nandakumar S, Miller CW, Kumaraguru U. T regulatory cells: an overview and intervention techniques to modulate allergy outcome. Clin. Mol. Allergy7, 5 (2009).
   PubMedGoogle Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell133(5), 775–787 (2008).
   PubMed Web of Science ®Google Scholar
• Thornton AM. T regulatory cells. Curr. Biol.15(15), R582 (2005).
   Google Scholar
• Prieto GA. Progression of endometriosis to cancer: too MUCh FOXP3+ regulatory T-cell response? Dis. Model Mech.4(2), 139–140 (2011).
   PubMedGoogle Scholar
• Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol.10(7), 490–500 (2010).
   PubMed Web of Science ®Google Scholar
• Wu MH, Lu CW, Chuang PC, Tsai SJ. Prostaglandin E2: the master of endometriosis? Exp. Biol. Med. (Maywood)235(6), 668–677 (2010).
   PubMed Web of Science ®Google Scholar
• Dawood MY, Khan-Dawood FS, Wilson L Jr. Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain. Am. J. Obstet. Gynecol.148(4), 391–395 (1984).
   PubMedGoogle Scholar
• Wu MH, Sun HS, Lin CC et al. Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis. Mol. Hum. Reprod.8(12), 1103–1110 (2002).
   PubMed Web of Science ®Google Scholar
• Akoum A, Lemay A, Maheux R. Estradiol and interleukin-1β exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells. J. Clin. Endocrinol. Metab.87(12), 5785–5792 (2002).
   PubMed Web of Science ®Google Scholar
• Sakamoto Y, Harada T, Horie S et al. Tumor necrosis factor-α-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-κ B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression. J. Clin. Endocrinol. Metab.88(2), 730–735 (2003).
   PubMedGoogle Scholar
• Akoum A, Jolicoeur C, Boucher A. Estradiol amplifies interleukin-1-induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis. J. Clin. Endocrinol. Metab.85(2), 896–904 (2000).
   PubMed Web of Science ®Google Scholar
• Akoum A, Lawson C, Mccoll S, Villeneuve M. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol. Hum. Reprod.7(9), 859–866 (2001).
   PubMed Web of Science ®Google Scholar
• Provinciali M, Di Stefano G, Muzzioli M, Garzetti GG, Ciavattini A, Fabris N. Relationship between 17-β-estradiol and prolactin in the regulation of natural killer cell activity during progression of endometriosis. J. Endocrinol. Invest.18(8), 645–652 (1995).
   PubMedGoogle Scholar
• Garzetti GG, Ciavattini A, Provinciali M, Muzzioli M, Di Stefano G, Fabris N. Natural cytotoxicity and GnRH agonist administration in advanced endometriosis: positive modulation on natural killer activity. Obstet. Gynecol.88(2), 234–240 (1996).
   PubMedGoogle Scholar
• Umesaki N, Tanaka T, Miyama M, Mizuno K, Kawamura N, Ogita S. Increased natural killer cell activities in patients treated with gonadotropin releasing hormone agonist. Gynecol. Obstet. Invest.48(1), 66–68 (1999).
   PubMedGoogle Scholar
• Wu MY, Chao KH, Chen Su et al. The suppression of peritoneal cellular immunity in women with endometriosis could be restored after gonadotropin releasing hormone agonist treatment. Am. J. Reprod. Immunol.35(6), 510–516 (1996).
   PubMed Web of Science ®Google Scholar
• Beato M, Klug J. Steroid hormone receptors: an update. Hum. Reprod. Update6(3), 225–236 (2000).
   PubMed Web of Science ®Google Scholar
• Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J. Clin. Endocrinol. Metab.85(8), 2897–2902 (2000).
   PubMed Web of Science ®Google Scholar
• Igarashi TM, Bruner-Tran KL, Yeaman GR et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil. Steril.84(1), 67–74 (2005).
   PubMed Web of Science ®Google Scholar
• Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics1(2), 106–111 (2006).
   PubMed Web of Science ®Google Scholar
• Arruvito L, Giulianelli S, Flores AC et al. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J. Immunol.180(8), 5746–5753 (2008).
   PubMed Web of Science ®Google Scholar
• Henderson TA, Saunders PT, Moffett-King A, Groome NP, Critchley HO. Steroid receptor expression in uterine natural killer cells. J. Clin. Endocrinol. Metab.88(1), 440–449 (2003).
   PubMed Web of Science ®Google Scholar
• Khan KN, Masuzaki H, Fujishita A et al. Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis. Hum. Reprod.20(7), 2004–2013 (2005).
   PubMedGoogle Scholar
• Lydon JP, Demayo FJ, Funk CR et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev.9(18), 2266–2278 (1995).
   PubMed Web of Science ®Google Scholar
• Tibbetts TA, Conneely OM, O’Malley BW. Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol. Reprod.60(5), 1158–1165 (1999).
   PubMed Web of Science ®Google Scholar
• Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, Mcbean J, Osteen KG. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J. Clin. Endocrinol. Metab.87(10), 4782–4791 (2002).
   PubMedGoogle Scholar
• Bruner-Tran KL, Zhang Z, Eisenberg E, Winneker RC, Osteen KG. Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget. J. Clin. Endocrinol. Metab.91(4), 1554–1560 (2006).
   PubMed Web of Science ®Google Scholar
• Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol.4(8), 617–629 (2004).
   PubMed Web of Science ®Google Scholar
• Heimler I, Rawlins RG, Owen H, Hutz RJ. Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of human luteinized granulosa cells. Endocrinology139(10), 4373–4379 (1998).
   PubMed Web of Science ®Google Scholar
• Moran FM, Vandevoort CA, Overstreet JW, Lasley BL, Conley AJ. Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: inhibition of estradiol secretion due to decreased 17α-hydroxylase/17,20-lyase cytochrome P450 expression. Endocrinology144(2), 467–473 (2003).
   PubMed Web of Science ®Google Scholar
• Pocar P, Fischer B, Klonisch T, Hombach-Klonisch S. Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction129(4), 379–389 (2005).
   PubMed Web of Science ®Google Scholar
• Porpora MG, Medda E, Abballe A et al. Endometriosis and organochlorinated environmental pollutants: a case–control study on Italian women of reproductive age. Environ. Health Perspect.117(7), 1070–1075 (2009).
   PubMed Web of Science ®Google Scholar
• Bofinger DP, Feng L, Chi LH et al. Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium. Toxicol. Sci.62(2), 299–314 (2001).
   PubMed Web of Science ®Google Scholar
• Bruner-Tran KL, Yeaman GR, Crispens MA, Igarashi TM, Osteen KG. Dioxin may promote inflammation-related development of endometriosis. Fertil. Steril.89(Suppl. 5), 1287–1298 (2008).
   PubMed Web of Science ®Google Scholar
• Tian Y, Ke S, Denison MS, Rabson AB, Gallo MA. Ah receptor and NF-κB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem.274(1), 510–515 (1999).
   PubMed Web of Science ®Google Scholar
• Baba T, Mimura J, Gradin K et al. Structure and expression of the Ah receptor repressor gene. J. Biol. Chem.276(35), 33101–33110 (2001).
   PubMed Web of Science ®Google Scholar
• Puga A, Barnes SJ, Chang C et al. Activation of transcription factors activator protein-1 and nuclear factor-κB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol.59(8), 997–1005 (2000).
   PubMed Web of Science ®Google Scholar
• Schlezinger JJ, Blickarz CE, Mann KK, Doerre S, Stegeman JJ. Identification of NF-κB in the marine fish Stenotomus chrysops and examination of its activation by aryl hydrocarbon receptor agonists. Chem. Biol. Interact.126(2), 137–157 (2000).
   PubMedGoogle Scholar
• Sulentic CE, Holsapple MP, Kaminski NE. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J. Pharmacol. Exp. Ther.295(2), 705–716 (2000).
   PubMed Web of Science ®Google Scholar
• Yu J, Wang Y, Zhou WH, Wang L, He YY, Li DJ. Combination of estrogen and dioxin is involved in the pathogenesis of endometriosis by promoting chemokine secretion and invasion of endometrial stromal cells. Hum. Reprod.23(7), 1614–1626 (2008).
   PubMedGoogle Scholar
• Quaranta MG, Porpora MG, Mattioli B et al. Impaired NK-cell-mediated cytotoxic activity and cytokine production in patients with endometriosis: a possible role for PCBs and DDE. Life Sci.79(5), 491–498 (2006).
   PubMed Web of Science ®Google Scholar
• Singh NP, Nagarkatti M, Nagarkatti P. Primary peripheral T cells become susceptible to 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in vitro upon activation and in the presence of dendritic cells. Mol. Pharmacol.73(6), 1722–1735 (2008).
   PubMed Web of Science ®Google Scholar
• Singh NP, Nagarkatti M, Nagarkatti PS. Role of dioxin response element and nuclear factor-κB motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression. Mol. Pharmacol.71(1), 145–157 (2007).
   PubMed Web of Science ®Google Scholar
• Bruner-Tran KL, Osteen KG. Developmental exposure to TCDD reduces fertility and negatively affects pregnancy outcomes across multiple generations. Reprod. Toxicol.31(3), 344–350 (2011).
   PubMed Web of Science ®Google Scholar